Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.69
0.03 (4.17%)
At close: Jun 16, 2025, 3:59 PM
0.69
-0.03%
After-hours: Jun 16, 2025, 07:49 PM EDT
Xilio Therapeutics Revenue
Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending March 31, 2025, Xilio Therapeutics generated $2.93M in revenue.
Revenue (ttm)
$6.34M
Revenue Growth
0%
Price / Sales Ratio
8.06
Revenue / Employee
$99.13K
Employees
64
Market Cap
35.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|